Trial intelligence / Profile preview

Intramuscular Peramivir in Uncomplicated Acute Influenza

NCT00610935Phase 3Terminated

Sponsor
BioCryst Pharmaceuticals, Inc.
Start
Jan 2008
Primary completion
Feb 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of peramivir in influenza, sponsored by BioCryst Pharmaceuticals, Inc.. Started Jan 2008; status: terminated.

02

Drugs

peramivir
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00610935.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00610935.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call